Skip to main content
. 2021 Aug 17;97(7 Suppl 1):S15–S24. doi: 10.1212/WNL.0000000000012425

Figure 1. Acceptable Cutaneous Neurofibroma (cNF) Treatment Response.

Figure 1

(A-B) Survey respondents were asked: “When thinking about the raised cutaneous neurofibromas that bother you the most, what is the minimum decrease in [number/size] that would be acceptable to you after participating in a treatment trial?” The questions were accompanied by baseline images and digitally manipulated into a series visually representing a 33%, 66%, and 100% decrease in cNF number and size. (A) Images used for cNF number decrease. (B) Graphical representation of the responses. (C) A 5-point Likert scale was utilized to assess agreement with the statements listed on the y axis.